Joint Filing AgreementJoint Filing Agreement • June 5th, 2023 • Biotechnology Value Fund L P • Investment advice
Contract Type FiledJune 5th, 2023 Company IndustryThe undersigned hereby agree that the Statement on Schedule 13G dated June 5, 2023 with respect to the Voting Common Stock, $0.0001 par value per share, of TScan Therapeutics, Inc., a Delaware corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.